How Long Before Wegovy Takes Effect: a Week-by-Week Guide

Step 1, the first four weeks: settling in, not stepping on the scales

The 0.25 mg starting dose of Wegovy is a tolerability dose. Its job is to let your body adjust to semaglutide's mechanism before the dose climbs. Most people experience some degree of reduced appetite during this period, meals feel satisfying sooner, leftovers accumulate in the fridge. What they often don't see yet is significant movement on the scales, and that's entirely normal.

Nausea, constipation and other gastrointestinal effects are most common in these first weeks, particularly in the day or two after each injection. Keeping the pen in a consistent spot in the fridge door can help build the injection into a weekly routine, reducing the mental load of a new habit. The NHS medicines page for semaglutide has clear guidance on what early side effects to expect and when to contact a clinician.

People who arrive at this stage expecting rapid, dramatic results sometimes feel discouraged. If you are wondering how long until Wegovy takes effect, the honest answer is that the first pen's purpose is adjustment. Weight loss at this step is modest for most, and that's by design.

Step 2, weeks four to sixteen: the dose climbs, appetite falls further

As the dose escalates from 0.5 mg to 1.0 mg and then to 1.7 mg, appetite suppression typically deepens. Many people describe this period as when Wegovy starts feeling genuinely different, portions shrink, high-calorie foods become less appealing, and the number on the scales begins to move more consistently.

By around week eight to twelve, measurable weight loss is evident for most people who are tolerating the medication well and have made the dietary adjustments their prescriber recommended. If you want a clearer picture of how long for Wegovy to take effect at each escalation step, the evidence suggests weight loss of around five to ten percent of body weight is common in this window for those who respond well, though individual results vary considerably.

It's worth reading more about how long Wegovy takes to work at different doses if you want a closer look at the escalation schedule and what trial participants experienced at each stage. The short version: this middle phase is often where confidence in the treatment builds.

Step 3, reaching and sustaining the maintenance dose

Wegovy's standard maintenance dose is 2.4 mg weekly, reached after roughly five months of gradual titration. The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults with obesity over 68 weeks and found an average body-weight reduction of around 15% at the 2.4 mg maintenance dose, alongside a reduced-calorie diet and increased physical activity. That figure is an average, some participants lost considerably more, some less.

For people whose prescriber deems it appropriate, the MHRA approved a higher 7.2 mg maintenance dose in 2026, with trials reporting around 20.7% average weight loss over 72 weeks at that level. Dose availability is confirmed at consultation; our Wegovy overview page covers the licensed dose pathway and what to expect at each step.

The broader point is that the full effect of semaglutide on weight accumulates over many months of maintained treatment, and many people are curious about Wegovy face before and after the changes that become visible at this stage alongside the changes in body weight. Stopping early (or at a sub-maintenance dose) means the results seen in the evidence base were never reached. Prescribers at our pharmacy review every repeat order before it is dispensed, in part to assess whether treatment is producing the expected response and whether any adjustment is needed.

What to do if Wegovy doesn't seem to be working

If appetite has not changed noticeably after four to six weeks at a given dose, or if weight loss has stalled for several weeks during the escalation phase, the right step is to raise it with your prescriber rather than adjust anything yourself. Several factors can blunt the response: inadequate sleep, very high stress levels, certain other medicines, and diet composition all play a role alongside the medication.

NICE's appraisal of semaglutide for weight management (NICE TA875) notes that continuing treatment should be reviewed if less than 5% weight loss has occurred after six months on the maintenance dose. That's a clinical benchmark, not a reason to stop prematurely, but it does underline that an honest assessment of response matters.

If you are weighing up your options, our weight-loss treatment overview sets out how semaglutide compares with other licensed approaches. Questions about cost are answered on our Wegovy pricing page. And if you'd like a clinician to assess whether you are a suitable candidate, starting a free consultation is the first step, a GPhC-registered prescriber, not an automated system, reads your answers the same day.